HALCION

This brand name is authorized in Austria, Germany, Estonia, Spain, Finland, Hong Kong, Ireland, Japan, Lithuania, Mexico, United States

Active ingredients

The drug HALCION contains one active pharmaceutical ingredient (API):

1 Triazolam UNII 1HM943223R - TRIAZOLAM

Triazolam is a short-acting benzodiazepine with anticonvulsant anxiolytic, sedative, muscle relaxant and amnesic properties. It is used as a hypnotic in the short-term management of insomnia. Read about Triazolam

Medication package inserts

Below package inserts are available for further reading:

Title	Information Source	Document Type
HALCION Tablet	Health Products Regulatory Authority (IE)	MPI, EU: SmPC

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code	Group title	Classification
N05CD05	Triazolam	N Nervous system → N05 Psycholeptics → N05C Hypnotics and sedatives → N05CD Benzodiazepine derivatives
Discover more medicines within N05CD05

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
Country: DE	Bundesinstitut für Arzneimittel und Medizinprodukte	Identifier(s): 02187391, 06497941
Country: EE	Ravimiamet	Identifier(s): 1037359, 1761498
Country: ES	Centro de información online de medicamentos de la AEMPS	Identifier(s): 58118
Country: FI	Lääkealan turvallisuus- ja kehittämiskeskus	Identifier(s): 199133
Country: HK	Department of Health Drug Office	Identifier(s): 00495
Country: IE	Health Products Regulatory Authority	Identifier(s): 27340, 27529
Country: JP	医薬品医療機器総合機構	Identifier(s): 1124007F1020, 1124007F2026
Country: LT	Valstybinė vaistų kontrolės tarnyba	Identifier(s): 1014878, 1067196, 1081944, 1087823
Country: MX	Comisión Federal para la Protección contra Riesgos Sanitarios	Identifier(s): 89847
Country: US	FDA, National Drug Code	Identifier(s): 0009-0017